Related Experiment Video
Updated: Jun 6, 2026
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Evidence and research perspectives for surgeons in the European Rectal Cancer Consensus Conference (EURECA-CC2)
V Valentini1, C Coco, M A Gambacorta
1Cattedra Radioterapia, Universit Cattolica del Sacro Cuore, Policlinico Universitario A. Gemelli.
Acta Chirurgica Iugoslavica
|November 12, 2010
Summary
Multidisciplinary rectal cancer treatment achieved broad European consensus, guiding future protocols and guidelines. This expert consensus aims to improve rectal cancer staging and treatment across Europe.
Area of Science:
- Oncology
- Public Health
Background:
- Rectal cancer management is increasingly multidisciplinary.
- The EURECA-CC2 conference aimed to establish European consensus on rectal cancer treatment.
Framework:
- The Delphi method was employed to achieve consensus.
- Eight key areas of rectal cancer management were addressed: epidemiology, diagnostics, pathology, surgery, radiotherapy/chemotherapy, toxicity/quality of life, follow-up, and research.
Implementation:
- 207 statements were voted on by committee members over three rounds.
- Disagreements were resolved through open debate during the conference.
- Consensus levels were categorized as 'large', 'moderate', or 'minimum'.
Implications:
- 86% of statements achieved large consensus, indicating strong agreement on rectal cancer management strategies.
- The consensus process provides a foundation for future European programs, protocols, and guidelines.
- Despite progress, significant research challenges in rectal cancer management persist.
